KPWS
RPRX icon

Kestra Private Wealth Services’s Royalty Pharma RPRX Stock Holding History

Kestra Private Wealth Services’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$442K Buy
7,881
+2,797
+55% +$146K ﹤0.01% 1314
2026
Q1 		$244K Buy
+5,084
New +$223K ﹤0.01% 1548

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kestra Private Wealth Services's RPRX Position: Q2 2026 in Review

Kestra Private Wealth Services increased its Royalty Pharma (RPRX) stake by 55% in Q2 2026, buying an estimated $146K and bringing the position to 7,881 shares worth $442K. The position accounts for ﹤0.01% of the portfolio, ranked #1314.

Kestra Private Wealth Services first reported a position in RPRX in Q1 2026 and has held it in 2 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Kestra Private Wealth Services held 7,881 shares of Royalty Pharma worth $442K as of Q2 2026.
  • Kestra Private Wealth Services bought 2,797 Royalty Pharma shares in Q2 2026, an estimated $146K.
  • Royalty Pharma made up ﹤0.01% of Kestra Private Wealth Services's portfolio in Q2 2026, its #1314 holding.
  • Kestra Private Wealth Services first reported a position in Royalty Pharma in Q1 2026 and has held it in 2 quarters since.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.